Notice2026-00053
National Human Genome Research Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 7, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 4 (Wednesday, January 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 4 (Wednesday, January 7, 2026)]
[Notices]
[Page 514]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the public, with attendance limited to
space available. The meeting will be videocast and can be accessed from
<a href="https://videocast.nih.gov/">https://videocast.nih.gov/</a> on the day of the meeting. Individuals who
plan to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: February 9, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To discuss matters of program relevance.
Address: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Rockledge,
MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Issel Anne Lim, Ph.D., Deputy Director, Division
of Extramural Operations, National Human Genome Research Institute,
National Institutes of Health, 6700B Rockledge Drive, Room 3186,
Bethesda, MD 20892, <a href="/cdn-cgi/l/email-protection#29405a5a4c454847474c0745404469474041074e465f"><span class="__cf_email__" data-cfemail="741d07071118151a1a115a181d19341a1d1c5a131b02">[email protected]</span></a>.
Any interested person may file written comments with the
committee no later than 15 days after the meeting by forwarding the
statement to the Contact Person listed on this notice. The statement
should include the name, address, telephone number and when
applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: <a href="http://www.genome.gov/council">http://www.genome.gov/council</a>, where an agenda and any
additional information for the meeting will be posted when
available.
Dated: January 5, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-00053 Filed 1-6-26; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 7, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.